-
Je něco špatně v tomto záznamu ?
In vitro antimalarial activity of synthesized TiO2 nanoparticles using Momordica charantia leaf extract against Plasmodium falciparum
Pachiyappan Rajiv Gandhi, Chidambaram Jayaseelan, Chinnaperumal Kamaraj, S. R. Radhika Rajasree, Rathinasamy Regina Mary
Jazyk angličtina Země Česko
Typ dokumentu práce podpořená grantem
- MeSH
- antimalarika * MeSH
- malárie farmakoterapie MeSH
- Momordica charantia chemie MeSH
- nanočástice MeSH
- nosiče léků MeSH
- oxidy MeSH
- Plasmodium falciparum účinky léků MeSH
- rostlinné extrakty farmakologie chemie MeSH
- techniky in vitro MeSH
- titan toxicita MeSH
- Publikační typ
- práce podpořená grantem MeSH
Malaria is a serious global health challenge, and it has infected millions of people worldwide. There is an urgent need for new antimalarial drugs and drug targets for both prophylaxis and chemotherapy. In the present study, we biosynthesized TiO2 nanoparticles (NPs) using the Momordica charantia leaf aqueous extract as a reducing and stabilizing agent. TiO2 NPs were characterized by UV, XRD, FTIR, HRTEM, EDX, DLS and Zeta-potential. The maximum activity of mosquitocidal was observed in the synthesized TiO2 NPs against Anopheles stephensi Liston (Diptera: Culicidae) larvae and pupae, LC50 were 2.50 mg/l (I instar), 2.86 mg/l (II), 3.29 mg/l (III), 3.43 mg/l (IV), and 5.04 mg/l (pupa). The antimalarial activity of M. charantia leaf aqueous extract and TiO2 NPs were evaluated against CQ-resistant (CQ-r) and CQ sensitive (CQ-s) strains of Plasmodium falciparum. IC50 of M. charantia leaf aqueous extract were 83.64 μg/ml (CQ-s) and 88.14 μg/ml (CQ-r). Synthesized TiO2 NPs achieved IC50 of 53.42 μg/ml (CQ-s) and 59.71 μg/ml (CQ-r). The TiO2 NPs did not exhibit any noticeable toxicity on Poecilia reticulata after 24 h of exposure. Overall, our results suggest that the synthesized TiO2 NPs may be employed to develop newer and safer agents for malaria control.
Periyar University Department of Biotechnology Salem Tamil Nadu India
Sathyabama University Centre for Ocean Research Chennai Tamil Nadu India
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18039924
- 003
- CZ-PrNML
- 005
- 20190323204152.0
- 007
- ta
- 008
- 181211s2018 xr da f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jab.2018.04.001 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Gandhi, Pachiyappan Rajiv $u Auxilium College (Autonomous), Department of Zoology, Division of Nanobiotechnology, Gandhi Nagar, Vellore District, Tamil Nadu, India
- 245 10
- $a In vitro antimalarial activity of synthesized TiO2 nanoparticles using Momordica charantia leaf extract against Plasmodium falciparum / $c Pachiyappan Rajiv Gandhi, Chidambaram Jayaseelan, Chinnaperumal Kamaraj, S. R. Radhika Rajasree, Rathinasamy Regina Mary
- 504 __
- $a Literatura
- 520 9_
- $a Malaria is a serious global health challenge, and it has infected millions of people worldwide. There is an urgent need for new antimalarial drugs and drug targets for both prophylaxis and chemotherapy. In the present study, we biosynthesized TiO2 nanoparticles (NPs) using the Momordica charantia leaf aqueous extract as a reducing and stabilizing agent. TiO2 NPs were characterized by UV, XRD, FTIR, HRTEM, EDX, DLS and Zeta-potential. The maximum activity of mosquitocidal was observed in the synthesized TiO2 NPs against Anopheles stephensi Liston (Diptera: Culicidae) larvae and pupae, LC50 were 2.50 mg/l (I instar), 2.86 mg/l (II), 3.29 mg/l (III), 3.43 mg/l (IV), and 5.04 mg/l (pupa). The antimalarial activity of M. charantia leaf aqueous extract and TiO2 NPs were evaluated against CQ-resistant (CQ-r) and CQ sensitive (CQ-s) strains of Plasmodium falciparum. IC50 of M. charantia leaf aqueous extract were 83.64 μg/ml (CQ-s) and 88.14 μg/ml (CQ-r). Synthesized TiO2 NPs achieved IC50 of 53.42 μg/ml (CQ-s) and 59.71 μg/ml (CQ-r). The TiO2 NPs did not exhibit any noticeable toxicity on Poecilia reticulata after 24 h of exposure. Overall, our results suggest that the synthesized TiO2 NPs may be employed to develop newer and safer agents for malaria control.
- 650 _2
- $a malárie $x farmakoterapie $7 D008288
- 650 _2
- $a Plasmodium falciparum $x účinky léků $7 D010963
- 650 12
- $a antimalarika $7 D000962
- 650 _2
- $a Momordica charantia $x chemie $7 D029777
- 650 _2
- $a rostlinné extrakty $x farmakologie $x chemie $7 D010936
- 650 _2
- $a titan $x toxicita $7 D014025
- 650 _2
- $a nanočástice $7 D053758
- 650 _2
- $a nosiče léků $7 D004337
- 650 _2
- $a techniky in vitro $7 D066298
- 650 _2
- $a oxidy $7 D010087
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jayaseelan, Chidambaram $u Sathyabama University, Centre for Ocean Research, Chennai, Tamil Nadu, India
- 700 1_
- $a Kamaraj, Chinnaperumal $u Periyar University, Department of Biotechnology, Salem, Tamil Nadu, India
- 700 1_
- $a Rajasree, S. R. Radhika $u Sathyabama University, Centre for Ocean Research, Chennai, Tamil Nadu, India
- 700 1_
- $a Rathinasamy, Regina Mary $u Auxilium College (Autonomous), Department of Zoology, Division of Nanobiotechnology, Gandhi Nagar, Vellore District, Tamil Nadu, India
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 16, č. 4 (2018), s. 378-386 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2018/04/17.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 4 $z 0
- 990 __
- $a 20181210075422 $b ABA008
- 991 __
- $a 20190323204521 $b ABA008
- 999 __
- $a ok $b bmc $g 1357998 $s 1036987
- BAS __
- $a 3
- BMC __
- $a 2018 $b 16 $c 4 $d 378-386 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $c NLK125 $d 20190323 $a NLK 2018-52/vt